×
Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder PDF
$ 40.00
Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder PDF quantity
$ 40.00
×
Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics PDF
$ 40.00
Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics PDF quantity
$ 40.00
×
Posttraumatic Stress Disorder Exacerbation as a Result of Public Masking in Times of COVID-19 PDF
$ 40.00
Posttraumatic Stress Disorder Exacerbation as a Result of Public Masking in Times of COVID-19 PDF quantity
$ 40.00
×
Antidepressant Medication Change in a Clinical Treatment Setting: A Comparison of the Effectiveness of Selective Serotonin Reuptake Inhibitors PDF
$ 40.00
Antidepressant Medication Change in a Clinical Treatment Setting: A Comparison of the Effectiveness of Selective Serotonin Reuptake Inhibitors PDF quantity
$ 40.00
×
The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients PDF
$ 40.00
The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients PDF quantity
$ 40.00
×
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder PDF
$ 40.00
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial PDF
$ 40.00
Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial PDF quantity
$ 40.00
×
Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report PDF
$ 40.00
Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report PDF quantity
$ 40.00
×
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders PDF
$ 40.00
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders PDF quantity
$ 40.00
×
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF
$ 40.00
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF quantity
$ 40.00
×
Outcome of Patients With Major Depressive Disorder After Serious Suicide Attempt PDF
$ 40.00
Outcome of Patients With Major Depressive Disorder After Serious Suicide Attempt PDF quantity
$ 40.00
×
Roles and Goals of a Palliative Care Psychiatrist PDF
$ 40.00
Roles and Goals of a Palliative Care Psychiatrist PDF quantity
$ 40.00
×
Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF
$ 40.00
Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF quantity
$ 40.00
×
Elevated Unconjugated Bilirubin in Schizophrenia Compared to Bipolar Affective Disorder PDF
$ 40.00
Elevated Unconjugated Bilirubin in Schizophrenia Compared to Bipolar Affective Disorder PDF quantity
$ 40.00
×
Successful Naloxone Challenge Test in a Patient With Atrial Flutter PDF
$ 40.00
Successful Naloxone Challenge Test in a Patient With Atrial Flutter PDF quantity
$ 40.00
×
Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder PDF
$ 40.00
Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder PDF quantity
$ 40.00
×
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study PDF
$ 40.00
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart